These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35805070)

  • 1. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats.
    Kim EY; Dryer SE
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trpc6 inactivation confers protection in a model of severe nephrosis in rats.
    Kim EY; Yazdizadeh Shotorbani P; Dryer SE
    J Mol Med (Berl); 2018 Jul; 96(7):631-644. PubMed ID: 29785489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions.
    Kim EY; Shotorbani PY; Dryer SE
    Biochem Biophys Rep; 2019 Mar; 17():139-150. PubMed ID: 30662960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TRPC6 Inactivation on Glomerulosclerosis and Renal Fibrosis in Aging Rats.
    Kim EY; Dryer SE
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats.
    Hassanzadeh Khayyat N; Kim EY; Dryer SE
    FASEB Bioadv; 2019 Dec; 1(12):773-782. PubMed ID: 32123821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPC6 enhances angiotensin II-induced albuminuria.
    Eckel J; Lavin PJ; Finch EA; Mukerji N; Burch J; Gbadegesin R; Wu G; Bowling B; Byrd A; Hall G; Sparks M; Zhang ZS; Homstad A; Barisoni L; Birbaumer L; Rosenberg P; Winn MP
    J Am Soc Nephrol; 2011 Mar; 22(3):526-35. PubMed ID: 21258036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
    Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
    Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.
    Dryer SE; Roshanravan H; Kim EY
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1041-1066. PubMed ID: 30953689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes.
    Chen S; He FF; Wang H; Fang Z; Shao N; Tian XJ; Liu JS; Zhu ZH; Wang YM; Wang S; Huang K; Zhang C
    Cell Calcium; 2011 Dec; 50(6):523-9. PubMed ID: 21959089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in TRPC6 channels abolishes their activation by hypoosmotic stretch but does not affect activation by diacylglycerol or G protein signaling cascades.
    Wilson C; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1018-25. PubMed ID: 24598806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin increases filtration barrier permeability via TRPC6-dependent activation of PKGIα signaling pathways.
    Rogacka D; Audzeyenka I; Rachubik P; Rychłowski M; Kasztan M; Jankowski M; Angielski S; Piwkowska A
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1312-1325. PubMed ID: 28263796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
    Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of TRPC3 or TRPC6 Fails to Attenuate the Formation of Inflammation and Fibrosis in Non-alcoholic Steatohepatitis.
    Nishiyama K; Toyama C; Kato Y; Tanaka T; Nishimura A; Nagata R; Mori Y; Nishida M
    Biol Pharm Bull; 2021; 44(3):431-436. PubMed ID: 33642551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.